Questions and answers on regulatory expectations for medicinal products for human use during the COVID-19 pandemic

2022 Health at a Glance Report highlights the need to… 5 December 2022 Over the last two years, major crises have had dramatic…
"Central Role For Industry Beckons As Europe Rebuilds After… 25 October 2021 Generics And Biosimilars Must Become A Central Policy Pillar, Says…
IGBA taking action to tackle shortages of antibiotic… 22 December 2022 The global generic medicines industry supplies most of the world’s…
Ready in a crisis: Medicines for Europe commits at one year… 8 December 2022 Medicines for Europe members are major suppliers of medicines for…